Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Pournima Kadam"'
Publikováno v:
Vaccines, Vol 8, Iss 4, p 655 (2020)
Background: Immune checkpoint blockade that downregulates T cell evasion for effective immunity has provided a renewed interest in therapeutic cancer vaccines. Methods: Utilizing murine lung cancer models, we determined: tumor burden, TIL cytolysis,
Externí odkaz:
https://doaj.org/article/a098544747b3433f94138d3b09254118
Autor:
Pournima Kadam, Sherven Sharma
Publikováno v:
Vaccines, Vol 8, Iss 2, p 317 (2020)
(1) Background: Targeting inhibitory immune checkpoint molecules has highlighted the need to find approaches enabling the activation of immune responses against cancer. Therapeutic vaccination, which induces specific immune responses against tumor an
Externí odkaz:
https://doaj.org/article/d762e114d88a4df6b3d4477075ecdc48
PDF File - (92K) -LNCaP/GFP and LNCaP/MT1-MMP-GFP cells were trypsinized and resuspended in the presence of 1�M H2-PFTMRos for 15 minutes at 37{degree sign}C. Cells were centrifuged, washed in PBS, and resuspended in phenol red-free RPMI, added to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dafb9b452ca655d547ca5db27e7b9ee
https://doi.org/10.1158/1541-7786.22519324
https://doi.org/10.1158/1541-7786.22519324
Autor:
Ram Pratap Singh, Jay M. Lee, Sherven Sharma, CA Usa Los Angeles, Pournima Kadam, Maie A. St. John, Michael Davoodi
Publikováno v:
AIMS Medical Science. 8:269-275
Targeting inhibitory immune checkpoint molecules has highlighted the need to find approaches enabling the induction and activation of an immune response against cancer. Therapeutic vaccination, which can induce a specific immune response against tumo
Publikováno v:
Vaccines, Vol 8, Iss 655, p 655 (2020)
Vaccines
Volume 8
Issue 4
Vaccines
Volume 8
Issue 4
Background: Immune checkpoint blockade that downregulates T cell evasion for effective immunity has provided a renewed interest in therapeutic cancer vaccines. Methods: Utilizing murine lung cancer models, we determined: tumor burden, TIL cytolysis,
Autor:
Sherven Sharma, Pournima Kadam
Publikováno v:
Vaccines
Volume 8
Issue 2
Vaccines, Vol 8, Iss 317, p 317 (2020)
Volume 8
Issue 2
Vaccines, Vol 8, Iss 317, p 317 (2020)
Background: Targeting inhibitory immune checkpoint molecules has highlighted the need to find approaches enabling the activation of immune responses against cancer. Therapeutic vaccination, which induces specific immune responses against tumor antige
Publikováno v:
Advances in experimental medicine and biology. 1231
CCL21 promotes immune activity in the tumor microenvironment (TME) by colocalizing dendritic cells (DC) and T cells programing ectopic lymph node architectural structures that correlate with cancer prognosis. Innovative strategies to deliver CCL21 in
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783030366667
CCL21 promotes immune activity in the tumor microenvironment (TME) by colocalizing dendritic cells (DC) and T cells programing ectopic lymph node architectural structures that correlate with cancer prognosis. Innovative strategies to deliver CCL21 in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40318d000594c75f40c8eb7a597bbc01
https://doi.org/10.1007/978-3-030-36667-4_7
https://doi.org/10.1007/978-3-030-36667-4_7
Autor:
Jian Cao, Alex Helkin, Hoang-Lan Nguyen, Stanley Zucker, Kevin Cao, Qian Zhang, Song Wu, Pournima Kadam, Ghassan J. Samara
Publikováno v:
Current Cancer Drug Targets. 16:618-630
Membrane type 1-matrix metalloproteinase (MT1-MMP, MMP-14) is associated with cancer invasion and metastasis leading to poor patient prognosis. MT1-MMP mediates cancer cell invasion via degradation of basement membrane and extracellular matrix, and i